Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Benign Prostatic Hyperplasia

Known as: Benign Hyperplasia of Prostate, Prostatic Hyperplasia, Benign, PROSTATIC HYPERPLASIA BENIGN <PROSTATISM> 
A non-cancerous nodular enlargement of the prostate gland. It is characterized by the presence of epithelial cell nodules, and stromal nodules… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
PURPOSE To revise the 2003 version of the American Urological Association's (AUA) Guideline on the management of benign prostatic… Expand
  • figure 1
  • figure 2
Highly Cited
2005
Highly Cited
2005
PURPOSE Benign prostatic hyperplasia (BPH), the most common benign neoplasm in American men, is a chronic condition that is… Expand
Highly Cited
2003
Highly Cited
2003
BACKGROUND Benign prostatic hyperplasia is commonly treated with alpha-adrenergic-receptor antagonists (alpha-blockers) or 5alpha… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
Highly Cited
2002
Highly Cited
2002
The prostate-specific antigen test has been a major factor in increasing awareness and better patient management of prostate… Expand
  • figure 2
  • figure 1
  • table 1
  • table 2
Highly Cited
1998
Highly Cited
1998
Background Finasteride is known to improve urinary symptoms in men with benign prostatic hyperplasia, but the extent to which the… Expand
Highly Cited
1993
Highly Cited
1993
  • P. Walsh
  • The Journal of urology
  • 1993
  • Corpus ID: 13550733
Background Benign prostatic hyperplasia is a progressive, androgen-dependent disease resulting in enlargement of the prostate… Expand
Highly Cited
1992
Highly Cited
1992
A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee… Expand
Highly Cited
1991
Highly Cited
1991
There is a strong suspicion among urologists that the prevalence of benign prostatic hyperplasia is higher than has been reported… Expand
Highly Cited
1987
Highly Cited
1987
To compare the clinical usefulness of the serum markers prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP), we… Expand
Highly Cited
1984
Highly Cited
1984
In this study we report the prevalence and growth rate of human benign prostatic hyperplasia with age by combining and analyzing… Expand